-
Validating the Use of Large Language Models to Generate Individual Patient-Level Data for Use in Health Technology Assessment
Sep 9, 2025, 16:22 PM -
Association Between Nonvalvular Atrial Fibrillation Type and Therapeutic Failure in Hospitalized Patients With History of Atrial Fibrillation Admitted to a Stepdown Unit
Sep 9, 2025, 16:22 PM -
Qualitative Insights Into Artificial Intelligence (AI) and Virtual Reality (VR) Training for Value Communication: Comparing Innovative Technologies With Traditional Methods in Pharma
Sep 9, 2025, 16:22 PM -
From Deficit Risk to Surplus Strength: A Revenue-Centered Analysis of Türkiye’s General Health Insurance 2015-2024
Sep 9, 2025, 16:22 PM -
Humanistic and Economic Burden of Primary Biliary Cholangitis: A Systematic Review of Health-Related Quality of Life Healthcare Resource Utilization and Associated Cost
Sep 9, 2025, 16:22 PM -
Resistance-Driven Treatment Failure: A Challenge to HCV Elimination in Pakistan
Sep 9, 2025, 16:22 PM -
The Relevance of Core Outcome Sets to Improving Healthcare Decision Making
Sep 9, 2025, 16:22 PM -
Assessing Treatment Efficiency Indicated in Rare Diseases: Learning From the CEESP Has Economic Opinions
Sep 9, 2025, 16:22 PM -
The Prevalence of COAs and DHTs for Studying Sleep Disorders in Clinical Trials
Sep 9, 2025, 16:22 PM -
Revisiting the Willingness-to-Pay Threshold in the Czech Republic: Integrating QALY Shortfall to Reflect Disease Severity and Unmet Medical Need
Sep 9, 2025, 16:22 PM -
The Next Frontier in HTA Reviewing the Integration of Artificial Intelligence and Discrete Event Simulation for Resource Modeling
Sep 9, 2025, 16:22 PM -
Enhancing Patient Involvement in European Health Technology Assessment (HTA): From Inconsistent National Practices to Systematic Engagement in Joint Clinical Assessments
Sep 9, 2025, 16:22 PM -
Evaluating the Effectiveness of FitterLife: A Community-Based Virtual Weight Management Program for Overweight Adults Without Diabetes or Hypertension in Singapore
Sep 9, 2025, 16:22 PM -
Transfusion-Related Cost and Time Burden in JAKi-Naïve and JAKi-Experienced Patients With Myelofibrosis Treated With Momelotinib and Ruxolitinib From the SIMPLIFY 1 and 2 Studies: A Brazilian Supplementary Health Perspective
Sep 9, 2025, 16:22 PM -
Estimating Quality-Adjusted Life Expectancy by Ethnicity for Application in Distributional Cost-Effectiveness Analysis
Sep 9, 2025, 16:22 PM -
The Cost-Effectiveness of an Artificial Intelligence Software for Stroke Imaging and Treatment Decisions in NHS Hospitals
Sep 9, 2025, 16:22 PM -
Integrating Patient Perspectives in HTA: What Can We Learn to Inform HTA-Focused Value Communications?
Sep 9, 2025, 16:22 PM -
The HTA Landscape of Orphan Products in the UK Between 2019 and 2024
Sep 9, 2025, 16:22 PM -
First-Line Immunotherapies for Advanced Biliary Tract Cancer: A Systematic Review of Economic Studies
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Delgocitinib vs. PUVA in Patients With Moderate-to-Severe Chronic Hand Eczema
Sep 9, 2025, 16:22 PM
